Title National Assembly Bio-Economy Forum “Korea, To Grow into a Global Top Pharmaceutical Power” 2017-08-22

GENUV (former, Shine Biopharma) attended "National Assembly Bio-Economy Forum" and the exerpt translation of the relevant article is as below.



National Assembly Bio-Economy Forum “Korea, To Grow into a Global Top Pharmaceutical Power” 


Sung-Ho Han, CEO of Shine Biopharma, pointed out that “It takes 5 to 6 years to discover drug candidates for new drug antibody platform, venture capital firms are interested in the projects that can achieve results within 3 years” and “because, unlike the United States, there is no government system in Korea that supports the mid to long-term innovative projects, each company has to raise money by itself to fund such projects.”  



To view the original article in Korean, please click here

Prev GENUV, To drive growth by finding partner for new drug development
Next Shine Biopharma, “Bridging the gap between early-stage technology and new drug development”